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High-affinity Cu(I) chelator PSP-2 as 
potential anti-angiogenic agent
Dorothea M. Heuberger1, Shefali Harankhedkar2, Thomas Morgan  2, Petra Wolint3, 
Maurizio Calcagni3, Barry Lai4, Christoph J. Fahrni2 & Johanna Buschmann  3
Copper is an essential trace metal that has been implicated in angiogenesis, the formation of new blood 
vessels. As tumor growth relies on establishing a functional capillary network for blood supply, copper 
chelation therapy may hold promise as an anti-cancer strategy by suppressing angiogenesis. To test the 
anti-angiogenic effect of PSP-2, a recently developed high affinity Cu(I) chelator with low zeptomolar 
dissociation constant, we utilized the endothelial cancer cell line EAhy926 and assessed changes in cell 
migration, proliferation, and tube formation in Matrigel. In addition, sprouting was assessed by the 
chicken and sheep aortic ring assay, and vascular pattern formation was studied in the chorioallantoic 
membrane of chicken embryos (CAM assay). While incubation with PSP-2 resulted in selective depletion 
of cellular copper levels, cell migration was not affected and the proliferating activity was even slightly 
increased. Moreover, the endothelial tube formation assay revealed significant morphological changes 
in the presence of PSP-2, with thicker tubular walls and an overall decreased meshes area. Similarly, 
the aortic ring assay and CAM assay showed that PSP-2 evokes significantly longer sprouts with smaller 
angles at branching points. Altogether, PSP-2 exhibits significant bioactivity at concentrations as low 
as 5 μM, rendering it a promising anti-angiogenic agent. As EAhy926 cells exhibit both endothelial and 
tumorigenic properties, the anti-angiogenic effect of PSP-2 might potentially translate also into anti-
cancer activity.
Copper is an important micronutrient involved in many fundamental biological processes1. An adequate supply 
of copper is not only critical for normal cell physiology but is also important in cancer progression2. Increased 
copper levels have been shown to stimulate angiogenesis, the formation of new blood vessels from existing vas-
culature, presumably by influencing the activity of proangiogenic factors, including VEGF, bFGF, TGFβ, and 
angiogenin3. Taking advantage of this effect, a range of biocompatible inorganic composite materials have been 
developed that promote vascularization in wound-healing by slow release of copper ions4–6. Conversely, copper 
depletion has emerged as a viable strategy to suppress vascularization in tumors7,8. For example, chelation therapy 
with penicillamine or tetrathiomolybdate has shown promising successes in reducing tumor growth, especially 
when combined with other anti-cancer regimens9. In addition, copper chelation has also been reported to induce 
anti-fibrotic and anti-inflammatory effects8.
The pro-angiogenic activity of copper cannot be reduced to a single target; rather, copper appears to play 
critical roles at multiple stages of angiogenesis3. At present, it remains unclear to what extent in vivo copper 
chelation affects the proliferation of endothelial cells or whether it suppresses blood vessel formation through 
a different mechanism. The mode of action might also differ between chelators, depending on the stability and 
redox potentials of the corresponding copper-complexes. For example, studies with tetrathiomolybdate suggest 
that its affinity is sufficient to sequester copper from cuproproteins such as ceruloplasmin, serum albumin, or 
metallothioneins. In addition, ternary cluster formation with Atox1, a copper-transporting metallochaperone, 
might block delivery to the trans-Golgi network where copper is inserted into nascent cuproproteins10.
We recently reported a membrane-permeant chelator, PSP-2, which binds Cu(I) with low zeptomolar disso-
ciation constant (logK = 20, 25 °C) and exhibits negligible affinity towards other biologically relevant divalent 
metal cations, including Mn(II), Fe(II), and Zn(II)11. Despite the high Cu(I) affinity, PSP-2 revealed low acute 
toxicity in cell culture up to a concentration of 100 µM over a period of 24 hours. In vitro studies demonstrated 
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that the chelator can intercept intracellular copper trafficking pathways, for example, by reversing copper-induced 
trafficking of the Menkes protein (ATP7A) or by blocking long-term potentiation of neurons in acute mouse 
hippocampal tissue slices11.
The favorable properties of PSP-2 as biological copper chelator thus prompted us to assess PSP-2 as a potential 
anti-angiogenic agent. To this end, we chose the human endothelial cancer cell line EAhy926 as a model sys-
tem12, which was previously used in the context of endothelial cell damage13,14. As an initial in vitro assessment 
of anti-angiogenic activity15, we explored the effect of PSP-2 on cellular proliferation and endothelial tube for-
mation. In addition, we utilized the chorioallantoic membrane of the chicken embryo (CAM assay)16,17 to assess 
the anti-angiogenic activity of PSP-2 in ovo. Furthermore, its effect on vascular sprouting was studied using the 
aortic ring assay18. The latter is an angiogenesis model where vascular sprouts are growing outside the aortic wall. 
In earlier studies, the assay has been employed to demonstrate the pro-angiogenic effect of copper, supplied in the 
form of CuSO419, and to test the anti-angiogenic impact of drugs20,21.
Hence, we hypothesized that
 (i) PSP-2 reduces EAhy926 cell proliferation,
 (ii) PSP-2 changes the tube formation pattern in EAhy926 cells,
 (iii) PSP-2 diminishes the sprouting in the aortic ring assay and
 (iv) PSP-2 hinders normal angiogenesis in the CAM assay.
Materials and Methods
Chemicals. PSP-2 (1,2-bis(bis(dimethylphosphorothioylmethyl)phosphino)ethane) was synthesized 
as previously described11. Avastin was purchased from Kantonsapotheke Zürich (Bevacizumab 25 mg/ml, 
Kantonsapotheke Zürich, Switzerland).
Cell culture. EAhy926 and murine NIH 3T3 cells were purchased from ATCC (LGC Standards GmbH, Wesel, 
Germany), and ATCC (Manassas, VA, USA), respectively. Passages P3-14 were used for all experiments. EAhy926 
cells were grown in DMEM (Gibco, Thermo Fisher Scientific, Reinach, Switzerland) containing 10% fetal bovine 
serum at 37 °C, 5% CO2, 95% humidity. NIH 3T3 mouse fibroblasts were cultured in Dulbecco’s Modified Eagle’s 
Medium (DMEM), supplemented with 10% bovine calf serum and 1% penicillin-streptomycin, at 37 °C under an 
atmosphere of humidified air containing 5% CO2.
Synchrotron X-ray fluorescence (SXRF) imaging. For SXRF imaging experiments, 3T3 mouse fibro-
blasts were grown on 5 × 5 mm silicon nitride windows (Silson Ltd., UK), pre-coated with 0.2 mg/mL solution of 
Human Fibronectin (Corning Cat. No. 354008). To increase copper levels above the limit of detection, cells were 
cultured in media supplemented with 50 µM CuCl2 which was removed prior to incubation with regular media 
containing 50 µM PSP-2 for 24 hours. Cells were then washed with PBS, fixed with a mixture of 3% paraformalde-
hyde and 1.5% glutaraldehyde in PBS for 20 min, washed again with PBS. The windows were air-dried overnight 
at room temperature by propping up on a rubber grid-mat placed in a covered sterile cell culture dish. SXRF 
imaging was performed at the 2-ID-D beamline of the Advanced Photon Source (Argonne National Laboratory, 
Argonne, USA). Cells were kept at room temperature under a He atmosphere and raster scanned through the 
Figure 1. SXRF elemental analysis. SXRF analysis of 3T3 mouse fibroblasts grown in medium supplemented 
with CuCl2 (50 µM) before (A,C,E) and after (B,D,F) treatment with the Cu(I)-selective high-affinity chelator 
PSP-2 (50 µM). (A,B) False-color elemental density maps for Cu and Zn. The minimum to maximum density 
range is indicated at the top of each micrograph. Scale bar: 10 µm. (C,D) X-ray fluorescence spectrum showing 
the emission bands of Fe, Co, Ni, Cu, Zn. (E,F) Total cellular content of copper and zinc normalized to total 
sulfur to account for differences in cell size (n = 3).
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incident beam with 10 keV excitation, which was focused to a spot size of 0.3 × 0.3 µm2 using a Fresnel zone 
plate22. Emission spectra were collected with a single-element fluorescence detector positioned at a 90 degree 
angle relative to the excitation beam, and elemental maps were generated by Gaussian fitting of the raw emission 
spectra using MAPS software23. Quantitative elemental densities were obtained by comparing the emission inten-
sities from the sample to those of a thin film standard (AXO Dresden, Germany).
Elemental quantification by total reflection x-ray fluorescence analysis (TRXF). EAhy926 
cells were cultured in DMEM supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 
37 °C under an atmosphere of humidified air containing 5% CO2. After growing cells in media supplemented 
with 50 µM CuCl2 for 24 h, the medium was replaced with regular medium with or without 50 µM PSP-2 and 
cells were incubated for another 24 h. Cells were then washed with PBS and harvested by trypsinization with 
trypsin-EDTA (1 mL). The cell count was determined with a hemocytometer, and cells were pelleted by cen-
trifugation at 5000 rpm at 4 °C for 5 min. For the determination of total content of copper, the cell pellets were 
disrupted using 200 µL of concentrated nitric acid and digested for 48 h at room temperature. The analysis by 
TRXF was performed using a Bruker S2 PICOFOX spectrometer and the digested samples were standardized by 
addition of 1 µg/mL of Ga(III).
Wound closure assay. EAhy926 cells were seeded into a non-coated 12 well plate (Techno Plastic Products 
AG, Trasadingen, Switzerland) in full media and allowed to reach confluency. Cells were scratched with a 10 µL 
tip (Starlab Group, Hamburg, Germany), washed three times with PBS before medium containing DMSO without 
and with PSP-2 at a final concentration of 5 µM was added. The wounded area was imaged at 20x magnification 
(Axiovert-10, Carl Zeiss AG) and analyzed at 0 h and 24 h post scratching using ImageJ (v1.47t; NIH, Bethesda, 
MA, USA). The size of the wound gap was measured at 3 random region of interests (ROI). Quantitative analysis 
of cell migration was performed based on the average wound gap from those ROIs, and the percentage of change 
was calculated using Eq. 1:
=
−
×change% (average space at time 0) (average space at time 16 h)
(average space at time 0 h)
100%
Figure 2. TRXF elemental analysis. TRXF elemental analysis of EAhy926 endothelial cells grown in medium 
supplemented with CuCl2 (50 µM) and treated with or without PSP-2. (A) Averaged x-ray fluorescence emission 
spectra derived from cells that were incubated for 24 hours with full medium in the absence (control) or 
presence of 50 µM PSP-2 (n = 5, averaged x-ray emission spectrum of 105 cells). (B) Quantification of the x-ray 
emission using Ga(III) as internal standard (n = 5).
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CCK-8 proliferation assay. EAhy926 cells were seeded into a non-coated 96 well plate (Techno Plastic 
Products AG, Trasadingen, Switzerland) in full media. After cells reached confluency, the growth medium was 
replaced with media containing DMSO ± PSP-2 at final concentrations of 5, 10, and 20 µM, and the cells were 
incubated for another 24 h. CCK-8 reagent (Sigma, Buchs SG, Switzerland) was added to the media one hour 
before the viability was assessed by measuring the OD at 450 nm.
Tube formation assay. EAhy926 cells were seeded into a 6-well plate and cultured in full media until 
they reached confluency. The cells were serum starved for one hour, washed with PBS, and harvested. Matrigel 
(Corning Matrigel Growth Factor Reduced Basement Membrane Matrix; Corning, NY14831, USA) was diluted 
1:1 with serum-free media and prewarmed at 37 °C in a 96 well plate. After seeding with approximately 85000 cells 
Figure 3. Wound closure assay with EAhy926 cells. A confluent monolayer of EAhy926 cells was scratched and 
the wound closure was assessed after 24 hours of migration towards the scratched area (covered area as fraction 
of whole area). PSP-2 was diluted into incubation buffer from a 5 mM stock solution in DMSO to yield a final 
concentration of 5 µM. For control experiments, an equivalent amount of DMSO without PSP-2 was added. 
Sample size n = 9. The p value between the two groups was 0.6404 (STUDENT’s t test).
Figure 4. Effect of PSP-2 on the proliferation of EAhy926 cells (CCK-8 assay). Absorbance of the CCK-8 
reagent at 450 nm of EAhy926 cells after 24 h exposure to PSP-2 at different concentrations, supplied from a 
DMSO stock solution. Control cells were treated with an equivalent amount of DMSO. Legend: DMSO: cells 
treated with DMSO only; DMSO + PSP-2: cells treated with equal amounts of DMSO and PSP-2. Sample size 
n = 9, analysis by (STUDENT’s t test).
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in serum free media on the Matrigel, the cells were incubated at 37 °C for 24 h in medium with DMSO ± PSP-2 
at a final concentration of 5 µM. Two to three images per well were captured at 10x magnification, using a phase 
contrast inverted microscope (Axiovert-10, Carl Zeiss AG, Feldbach, Switzerland), equipped with a digital cam-
era. Images were analyzed using the Angiogenesis Analyzer, a plugin developed for the ImageJ (Version 1.47t; 
NIH, Bethesda, MA, USA).[ref]
Aortic ring assay. (A) Chicken: Fertilized Lohman white LSL chicken eggs were purchased from Animalco 
AG, Switzerland, and incubated at 37 °C and 65% relative humidity in an incubator for 14 days. For experiments 
in chicken embryos until embryonic day 14 no IACUC approval is required according to Swiss animal care guide-
lines (TSchV, Art. 112). On incubation day 14, the aorta was carefully extracted according to established proto-
cols24. Briefly, chick embryo aortic arches were excised after exposure of the chicken heart. Excess tissue around 
the aortic arches was removed and 2–3 rings per arch were achieved by cutting the arches perpendicularly. Aortic 
rings were imbedded in Matrigel and exposed to 3 groups of culture media; DMEM with DMSO, DMSO + PSP-2, 
or avastin, a non-copper based anti-angiogenic drug (positive control). For each of the 3 groups, 10 rings were 
used. (B) Sheep: For the sheep aortic ring assay, sheep aorta was dissected in disks of 5 mm in diameter. For 
experiments with sheep aorta from dead sheep, no IACUC approval is required according to Swiss animal care 
guidelines (TSchV). The disks were subsequently incubated in Matrigel and exposed to 2 groups of culture media; 
DMEM with either DMSO or DMSO + PSP-2. For each group, n = 5 rings were used. For quantitative assessment 
of morphological differences upon PSP-2 treatment, the number of sprouts within a defined region of interest 
(ROI) were counted (n = 7) and the branch lengths between two junctions were measured based on relative 
length units, with n = 158 and n = 190 for DMSO and DMSO + PSP-2, respectively. Angles between branches 
were assessed within the same ROI, with n = 94 and n = 122 for DMSO and DMSO + PSP-2, respectively. All 
quantitative readouts were evaluated with Synedra View 18.0.0.7 software.
CAM assay. Fertilized Lohman white LSL chicken eggs were purchased from Animalco AG, Switzerland, and 
incubated at 37 °C and 65% relative humidity in an incubator for 3.5 days. For experiments in chicken embryos 
until embryonic day 14 no IACUC approval is required according to Swiss animal care guidelines (TSchV, Art. 
112). Then, using a drill, a window was created in the eggshell after removing 2 mL of albumen25. The window 
was covered with a petri dish and incubated at 37 °C for another 3.5 days as described earlier26. On incubation 
day (ID) 7, a 5 mM stock solution of PSP-2 in DMSO was diluted into incubation buffer to a final concentration 
of 5 µM, and 100 uL of this solution was dripped onto the CAM surface with a silicone ring of 1 cm in diame-
ter, confining the area of spreading liquid (control: diluted DMSO without PSP-2). On ID 8, another 100 µL of 
DMSO ± 5 µM PSP-2 were applied. On ID 14, at the end of the experiment, images were acquired of the whole 
ring. The sample size for each group was n = 4. For quantitative assessment, the lengths of the branches were 
determined based on relative length units using Synedra View 18.0.0.7 software, with n = 131 and n = 86 for 
DMSO and DMSO + PSP-2, respectively. Angles between branches were analyzed based on n = 91 and n = 36 for 
DMSO and DMSO + PSP-2, respectively.
Figure 5. Tube formation assay with EAhy926 cells. The effect of PSP-2 on tube formation (A) is expressed by 
wall thickening (B, arrows, and C (Kruskal Wallis test)) and by total meshes area (D, 1-way ANOVA). PSP-2 was 
diluted into incubation buffer from a 5 mM stock solution in DMSO to yield the indicated final concentrations. 
For control experiments, an equivalent amount of DMSO without PSP-2 was added.
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Statistical analysis. Data were analysed with StatView 5.0.1 and SPSS Statistics Version 25. Data were 
checked for normal distribution with Kolmogorov-Smirnow and Shapiro-Wilk tests. If data were not normally 
distributed, non-parametric tests, such as Kruskal Wallis test for more than 2 groups or Mann Whitney test for 
2 groups, were conducted. For normal distribution, parametric one-way analysis of variance (one-way ANOVA) 
was conducted for more than 2 groups. Pairwise comparison probabilities (p values) were calculated using the 
Fisher’s PLSD. P values less than 0.05 were considered significant. Unpaired t tests were conducted for the com-
parison of 2 groups. The p values were indicated for pairs that were significantly different. Values were expressed 
as means ± standard deviations.
All methods were carried out in accordance with the relevant Swiss animal care guidelines and regulations.
Figure 6. Aortic ring assay. Qualitative assessment of outgrowth endothelial cells (A). DMSO treatment has 
no effect on network formation (left), while DMSO + 5 µM PSP-2 leads to fewer branches but longer sprouts 
in the chicken aortic ring assay (middle). With avastin, an anti-angiogenic agent, no sprouting was observed 
(right). Prevalent outgrowth structures are schematically shown below. Quantitative readouts (B), with number 
of sprouts within a region of interest (ROI); length of branches between two junctions and angle between 
branches, analyzed by Mann Whitney test. For comparison, sheep aortic ring assay was performed, showing 
similar effects of outgrowth patterns as found in the chicken aortic ring assay (see Supporting Information, SI 
Fig. 2).
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Results
PSP-2 reduces total cellular copper without altering zinc or iron levels. In earlier studies, we 
demonstrated that PSP-2 can readily traverse cell membranes and intercept copper-dependent intracellular path-
ways11,27. To investigate whether the effects of PSP-2 actually correspond to selective removal of cellular copper, 
we visualized changes in trace metal content by synchrotron x-ray fluorescence (SXRF) microscopy using 3T3 
mouse fibroblasts as a model cell line (Fig. 1). Because endogenous copper levels are low, often residing at the 
limit of detection for single cell SXRF analysis, cells were grown in media supplemented with 50 µM CuCl2. As 
evident from the false-color density maps, zinc and copper showed similar distribution patterns with a pro-
nounced nuclear localization (Fig. 1A). Upon incubation with 50 µM PSP-2 for 24 h, copper levels decreased 
to approach the limit of detection, while zinc levels remained unaffected (Fig. 1B). A comparison of the cor-
responding x-ray fluorescence emission spectra, averaged over the entire cell area, best illustrate the effect of 
PSP-2 (Fig. 1C,D). While the copper signal dramatically decreased, iron and zinc remained essentially unaltered. 
Further quantification relative to a NIST standard yielded an approximately 3-fold decrease in the cellular copper 
content whereas the average zinc content remained unchanged upon PSP-2 treatment (Fig. E,F). To account for 
differences in cell size, the integrated copper and zinc densities were normalized to the sulfur content of each cell.
To test the effect of PSP-2 with cells relevant to angiogenesis, we determined changes of the average elemental 
content using the human umbilical vein endothelial cancer cell line EAhy926. Elemental analysis of the average 
copper content by total reflection x-ray fluorescence analysis (TRXF) revealed a dramatic effect after incubat-
ing with PSP-2 for 24 h with a greater than 20-fold decrease compared to control (Fig. 2). In agreement with 
above SXRF data, the relative x-ray emission signals for zinc and iron remained unaffected by PSP-2 (Fig. 2A). 
Altogether, these data demonstrate that PSP-2 is able to selectively reduce copper levels within the complex chem-
ical environment of a live cell.
Wound closure and cellular proliferation assay with EAhy926 endothelial cells. The stimulat-
ing effect of copper on endothelial cell proliferation is well documented28. To explore whether PSP-2-mediated 
copper sequestration might affect wound healing, we performed an in vitro scratch assay with EAhy926 cells. In 
this assay, cell migration is monitored over time after creating a “scratch” in a confluent cell monolayer29,30. As 
evident from Fig. 3, after 24 hours we observed no statistically significant difference in cell migration between 
cells exposed to 5 µM PSP-2, supplied from a 5 mM stock solution in DMSO, and cells treated with DMSO at the 
same concentration after a 1:1000 dilution.
In order to assess the effect of PSP-2 on cellular proliferation, we performed a CCK-8 viability assay. While at 
low concentrations of PSP-2 the proliferation of EAhy926 cells was slightly enhanced, we observed no significant 
Figure 7. Angiogenesis assessed by the CAM assay. A solution of 200 µL of DMSO ± PSP-2, which was diluted 
in incubation buffer to a final concentration of 5 µM PSP-2, was dripped onto the CAM surface, followed by 
a second application after 24 hours. Images were acquired 7 days after the first application (A). Quantitative 
assessment of the length of branches between two junctions and angle between branches (B), analyzed by Mann 
Whitney test.
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difference at 20 µM PSP-compared to untreated control cells (Fig. 4). Although small, the increases in cellular 
proliferation at 5 and 10 µM ligand concentrations were statistically significant.
Tube formation assay with EAhy926 cells. When plated on Matrigel, endothelial cells form 
capillary-like mesh structures within a few hours, thus offering a convenient model for the rapid screening of 
angiogenesis inhibitors31. In the presence of 5 or 10 µM PSP-2, tube formation resulted in a visual change in 
morphology with a significant increase in wall thickness as well as a reduction in the number of tubular walls 
(Fig. 5, and Supporting Information, SI Fig. 1). In addition, PSP-2 treatment reduced the total meshes area at both 
incubation concentrations.
Outgrowth of endothelial cells using the chicken aortic ring assay. Contrary to the effect of avastin, 
a potent inhibitor of angiogenesis, the outgrowth of endothelial cells in the chicken aortic ring assay was not com-
promised in the presence of PSP-2; however, the outgrowth pattern was distinctly different compared to control. 
While in the presence of DMSO alone a regular network was formed, the presence of PSP-2 led to a network with 
fewer branches and overall elongated vessels, which assumed a parallel alignment to each other (Fig. 6).
CAM assay. The CAM assay has been frequently used to study pro- and anti-angiogenic effects evoked by 
drugs32 or biomaterials33 placed on the chorioallantoic membrane of living chicken embryo34,35. Moreover, vascu-
larization can be assessed not only by histology ex vivo but also longitudinally at different time points by MRI in 
ovo26. Finally, the CAM assay is inexpensive and easy to execute. Application of PSP-2 in the CAM assay revealed 
a distinct change in the vascular pattern (Fig. 7). Major structural differences upon PSP-2 application were found 
in a reduced number of branches and in longish vessels compared to treatment with DMSO only, which was used 
as control.
Discussion
In this study, we demonstrated that the high-affinity Cu(I)-chelator PSP-2 exhibits significant anti-angiogenic 
effects. Consistent with previous metal ion selectivity studies in aqueous buffer11, treatment of 3T3 cells with 
PSP-2 resulted only in a decrease of copper levels without affecting other biologically relevant transition metals 
such as iron and zinc (Fig. 1). Moreover, the subcellular distribution of zinc remained qualitatively unchanged as 
revealed by x-ray fluorescence microscopy (Fig. 1). Likewise, PSP-2 selectively removed copper from EAhy926 
cells, which were chosen as a model cell line as it offers both endothelial as well as tumorigenic characteristics 
(Fig. 2).
Despite the ability to deplete total copper levels, PSP-2 did not reduce cellular proliferation and migration 
(Figs 3 and 4). At low incubation concentrations, cell proliferation even increased by approximately 10% in the 
presence of 5 μM PSP-2, and around 5% with 10 μM PSP-2. At a concentration of 20 μM PSP-2, however, there 
was no significant difference compared to untreated control cells (Fig. 4). These data contrast the effect of tetrathi-
omolybdate, which inhibited proliferation of human umbilical vein endothelial cells (HUVECs) already at a con-
centration as low as 2 µM36, or of other anti-angiogenic agents such as Sorafenib, which reduced proliferation of 
HUVECs by 40% at a concentration of 4 μM37. However, as cellular proliferation might be differently regulated in 
the EAhy926 cancer cell line, the HUVECs studies are not directly comparable.
The most striking anti-angiogenic effect of PSP-2 was observed during network formation of EAhy926 cells. 
In the presence of 5 μM PSP-2, we observed a pronounced wall thickening as well as a significant reduction of the 
total meshes area (Fig. 5). Similar effects were reported for tetrathiomolybdate36 as well as the anti-angiogenic 
agent arsenic oxide (As2O3)37. In the presence of PSP-2, vascular tube formation was disrupted in favor of cell 
accumulation at branching points to produce fewer but much thicker walls. The morphology of the networks 
formed in the presence of PSP-2 completely differed from the control. These results parallel earlier reports where 
copper chelation had no effect on endothelial process formation but resulted in almost complete inhibition of 
network formation38. As the tube formation assay is usually performed with HUVECs39 and includes different 
aspects of angiogenesis, such as endothelial cell adhesion, migration, alignment, and tube formation, it is note-
worthy that PSP-2 affected tube formation of EAhy926 cells, which represent not only endothelial cell character-
istics but also tumorigenic properties.
The in vitro anti-angiogenic activity of PSP-2 in the tube formation assay was further confirmed by two addi-
tional assays, the aortic ring assay as well as the CAM assay. Previous reports showed that bovine aortal cell 
migration was significantly increased in the presence of 1 μM CuSO419, thus underscoring the role of copper in 
angiogenesis3,40. In the chicken aortic ring assay, 5 μM PSP-2 did not suppress outgrowth of endothelial cells as 
observed with the inhibitor avastin, which was used as positive control. However, the outgrowth pattern signifi-
cantly changed to yield longer sprouts with fewer branching points (Fig. 6A). Quantitative readouts in the aortic 
ring assay could be assessed only beyond a cell-dense area of fibroblasts. Although the number of endothelial cell 
sprouts was very similar, the lengths of the branches were significantly higher in the samples that were incubated 
with PSP-2. Moreover, PSP-2 treatment led to significantly smaller angles between the branches (Fig. 6B).
A similar vessel pattern was found in the CAM assay, where PSP-2 suppressed branching, in favor of long, 
parallel arranged vessels within the silicone ring (Fig. 7A). Likewise, the length of the branches was significantly 
increased in the samples that were treated with PSP-2, with significantly smaller angles between the branches 
(Fig. 7B). Taken together, both assays confirmed the results found in the tube formation assay with EAhy926 cells. 
Endothelial cells from the chicken aorta as well as vessel sprouting on the chorioallantoic membrane (including 
primarily endothelial cells), were hindered to form regular tube-like structures.
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Conclusions
In this study, we showed that PSP-2, a high-affinity Cu(I) chelator with low zeptomolar dissociation constant, 
selectively reduces cellular copper levels and exhibits significant anti-angiogenic activity in the tube formation 
assay performed with EAhy926 endothelial cancer cells. Moreover, PSP-2 treatment resulted in significantly 
longer sprout branches with smaller angles in the chicken aortic ring assay. Finally, PSP-2 applied in the CAM 
assay significantly elongated vessel branches and reduced the angle between vessels. In light of the tumorigenic 
nature of EAhy926, PSP-2 might harbor not only anti-angiogenic, but also anti-tumorigenic activity, worthwhile 
of further exploration in an animal model. In addition, further research is needed to evaluate anti-cancer effects 
of PSP-2 in comparison to and in combination with other anti-cancer drugs.
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